Market Tracker

07/22 6:05pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
14.21 +0.30 / +2.16%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
14.18 -0.03 / -0.21%
 
Volume: 24.6K

Today’s Trading

Previous close13.91
Today’s open13.97
Day’s range13.95 - 14.44
Volume1,090,873
Average volume (3 months)1,702,472
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-21.38%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book25.32

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.05+0.57%
NKTRNektar Therapeutics+0.07+0.64%
ARIAARIAD Pharmaceutical...-0.05-0.97%
BRLIBio-Reference Labora...+0.20+0.66%
Data as of 4:00pm ET, 07/22/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts